Skip to content

Tuina Therapy for Patients with Chronic Fatigue Syndrome: a randomised controlled trial

Research on the Construction of an Integrated Model for the Prevention and Treatment of Chronic Fatigue Syndrome with the Characteristics of Traditional Chinese Medicine Tuina Therapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000002
Enrollment
Unknown
Registered
2025-01-01
Start date
2024-04-10
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic fatigue syndrome

Interventions

Sponsors

Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: According to the consensus on CFS diagnosis established by CDC in 1994 as follows: 1) persistent or recurrent fatigue lasting more than 6 months; 2) other organic diseases causing chronic fatigue must be excluded based on medical history physical examination or laboratory findings. And meets at least 4 of the following 8 symptom criteria: 1) self-reported impairment in short-term memory or concentration; 2) sore throat; 3) lymph nodes; 4) muscle pain; 5) multijoint pain without redness or swelling; 6) headaches of a new type pattern or severity; 7) unrefreshing sleep; 8) postexertional malaise lasting more than 24 hours.

Exclusion criteria

Exclusion criteria: Participants will not be enrolled if they meet any of the following criteria: 1) no complaint of fatigue or presenting with fewer than 4 accompanying symptoms; 2) fatigue symptoms alleviated by rest; 3) fatigue does not cause a significant decline in work ability educational performance social activities recreational activities or personal life; 4) presence of conditions known to cause fatigue such as cancer diabetes or autoimmune diseases; 5) severe cardiac pulmonary hepatic renal dysfunction or thyroid dysfunction; 6) presence of a psychiatric disorder; 7) pregnant or breastfeeding women; 8) use of medications or non-pharmacological treatments within 7 days prior to enrollment; 9) participation in other clinical trials simultaneously.

Design outcomes

Primary

MeasureTime frame
Chalder Fatigue Questionnaire;

Secondary

MeasureTime frame
Short-Form 36 bodily pain subscale (SF-36 BP);Hospital Anxiety and Depression Scale;Pittsburgh Sleep Quality Index;Short-Form 36 physical function subscale (SF-36 PF);

Countries

China

Contacts

Public ContactMin Fang

Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine

fm-tn0510@shutcm.edu.cn18930658005

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026